A case of chronic myelogenous leukemia with the T315I mutation who
progressed to myeloid blast phase and was successfully treated with
Patients with chronic myelogenous leukemia (CML) harboring the T315I
mutation who progress to blast phase CML while on ponatinib may be
successfully treated with asciminib monotherapy following induction
therapy with cytotoxic chemotherapy.